SCHEMBL20125964

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL20126074	0.90	CYP1A2 (0.46)	CA12CA1CA2CA9SMN1; SMN2
	SCHEMBL20125945	0.86	DNM1 (0.42)	MEN1KMT2AALDH1A1TSHRLTA4H
	SCHEMBL20125957	0.83	TSHR (0.50)	ALDH1A1TSHRDNM1
	SCHEMBL20125956	0.81	KMT2A (0.53)	CA12MGAMGAASIMGAM2
	SCHEMBL20125982	0.81	CA12 (0.56)	CA12CA1CA2CA9SMN1; SMN2
	SCHEMBL20125989	0.81	TSHR (0.49)	GAAMEN1KMT2AALDH1A1TSHR
	SCHEMBL23420998	0.81	DNM1 (0.53)	TSHRDNM1
	SCHEMBL20125921	0.81	DNM1 (0.53)	TSHRDNM1
	SCHEMBL20125992	0.81	CYP1A2 (0.39)	SMN1; SMN2CYP1A2MGAMGAASI
	SCHEMBL7670646	0.79	CA12 (0.44)	CA12CA1CA2CA9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.